Authors/Disclosures
|
Revere P. Kinkel, MD, FAAN
(University of California San Diego)
|
Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Kinkel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Kinkel has received research support from Department of Defense. The institution of Dr. Kinkel has received research support from PCORI. The institution of Dr. Kinkel has received research support from Sanofi. |
|
Paul W. O'Connor, MD
|
No disclosure on file |
|
Jack H. Simon, MD, PhD
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Susan E. Goelz, PhD
(myelin repair foundation)
|
No disclosure on file |
|
Robert Hyde, PhD
(Biogen)
|
Dr. Hyde has received personal compensation for serving as an employee of Biogen International GmbH . Dr. Hyde has received stock or an ownership interest from Biogen . |
|
Stefan Lanker, PhD
|
No disclosure on file |
|
Amy Pace, ScD
|
No disclosure on file |
|
Alfred W. Sandrock, MD, PhD
(Biogen)
|
No disclosure on file |
|
Hao Zhang, PhD
(Biogen Idec)
|
No disclosure on file |